MKMohammed Tayeb Oucif Khaled

Mohammed Tayeb Oucif Khaled

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mohammed Tayeb Oucif Khaled has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Multifunctional Ag/ZnO. Nanocomposites: Synthesis, Characterization, and Potent Antioxidant, Antibiofilm, and Anti‐Inflammatory Activities

    by Laid Zeghoud, Abderrhmane Bouafia, Ibtissam Laib, Manel Azzi, Mohammed Adel Mesbahi, Souhaila Meneceur, Salah Eddine Laouini, Mohammed Tayeb Oucif Khaled

    Ag/ZnO nanocomposites have attracted significant interest due to their enhanced physicochemical properties and wide‐ranging biomedical applications. In this study, the nanocomposites were successfully synthesized and thoroughly characterized. X‐ray diffraction confirmed the presence of a highly crystalline hexagonal ZnO structure with incorporated metallic Ag nanoparticles; the crystallite size, determined by the Scherrer equation, was approximately 55 nm. Scanning electron microscopy revealed quasi‐spherical particles exhibiting uniform morphology and good dispersion. UV–Vis spectroscopy displayed a prominent absorption band at 383 nm and a narrowed optical band gap of 1.70 eV, indicating strong electronic interactions between Ag and ZnO, along with improved surface reactivity. Biological evaluation demonstrated potent multifunctional activities. In the DPPH assay, the nanocomposites showed concentration‐dependent antioxidant activity, achieving 79% radical scavenging at 400 µg/mL, with an IC 50 of 166.79 µg/mL. The FRAP assay confirmed strong reducing power, rising from 120.22 to 760.37 µM Fe 2 + /g with increasing concentration. The materials exhibited excellent antibiofilm effects against pathogenic bacteria, inhibiting biofilm formation by up to 90%. Additionally, they effectively inhibited protein denaturation in the anti‐inflammatory assay, yielding an IC 50 of 137.83 µg/mL. These findings underscore the substantial biomedical potential of Ag/ZnO nanocomposites.

  • 4E (energy–exergy–economic–environmental) analysis of a natural gas–assisted hybrid indirect greenhouse dryer for continuous drying

    by Ali Zine, Abdelouahab Benseddik, Rachid Saim, Abdeldjalil Laouini, Messaoud Zelaci, Seif Eddine Bousbia Salah, Mohammed Tayeb Oucif Khaled, Biya Bouras, Mohammed Abdelbassit Kherrafi, Yunfeng Wang, et al.

  • Open Access

    Thermal Efficiency and Water Output Improvement in Modified Solar Distillers: A Comparative Study

    by Abdeldjalil Laouini, Ali Zine, Abderrahmane Khechekhouche, Mehdi Jahangiri, Samir Guediri, Mohammed Tayab Oucif Khaled, Massoud Zelaci

    This study evaluates the performance of a solar distiller‐assisted by a concentrator system (SDACS) compared to a controlled solar distiller (CSD). Analysis of the temperatures of the distillers revealed that the SDACS maintained higher temperatures throughout the experiment, with the maximum water temperature reaching 86.3°C, compared to 76.1°C for the CSD. This improved thermal retention contributed to significantly higher hourly and accumulated water outputs in the SDACS, which reached 480 mL/h and a total accumulation of 5404 mL, respectively, compared to 192 and 1955 mL for the CSD. The SDACS also demonstrated higher thermal efficiency, peaking at 180% compared to 60% for the CSD. In addition, the exergy efficiency of the SDACS was significantly higher, reaching 12.39% compared to 3.32% for the CSD. The SDACS distiller yields much higher revenue than the CSD distiller due to its increased output, offering a short payback period of approximately 4 months and a strong return on investment (ROI) of 308%. These results highlight the effectiveness of the design improvements of the SDACS, which significantly improve its ability to convert solar energy into thermal energy and useful work, resulting in overall performance and production efficiency in freshwater.